Rajesh Asarpota New CFO at NuVasive

Rajesh (Raj) J. Asarpota, recently chief financial officer (CFO) of Questcor Pharmaceuticals, is the new executive vice president and CFO at NuVasive, Inc. (effective September 1, 2017).

As the company wrote in its August 15, 2017 news release, “Asarpota will be responsible for the company’s global finance functions including accounting, FP&A, treasury and tax. He joins NuVasive with nearly 25 years of experience in financial and executive leadership roles across the healthcare industry.”

“Asarpota began his career at General Electric (GE) in the GE Financial Management program, including finance roles in commercial operations, plant and manufacturing analysis, sourcing and R&D analysis. He then joined the GE Corporate Audit Staff program and from there moved to GE Healthcare where he held a variety of key finance operating roles.”

“In the last 15 years, he has accumulated critical experience in both public and private enterprises, highlighted by his decade-long tenure at Life Technologies where he helped drive the growth from a small biotech company to a $4 billion life sciences leader. More recently, Mr. Asarpota was the CFO of publicly-traded Questcor Pharmaceuticals and supported the sale of that company, and then worked in private equity-backed healthcare companies for the last several years in executive financial and operational roles. Asarpota earned a bachelor’s degree from the University of Bombay in Bombay, India and an MBA from Marquette University in Milwaukee, Wisconsin.”

“Raj brings a strong financial and operational background to the NuVasive leadership team as we continue to focus on driving revenue growth and expanding profitability,” said Gregory T. Lucier, NuVasive’s chairman and CEO. “I have worked closely with Raj at multiple companies where we were successful at expanding market share and transforming operations. He’s a proven leader who will drive significant shareholder value.”

Asarpota told OTW, “I’m eager to jump right in and start working with the strong finance team that NuVasive has built and help drive the goals the company has established. I am very fortunate that have worked with many of those on the executive team in the past and so I expect to quickly ramp up my knowledge of the spine industry, the company and our strategic plan for continued growth and profitability.”

“It is a rare opportunity to join a company like NuVasive with so much opportunity ahead of it. The company is taking market share and growing its top line, while also executing against initiatives to expand profitability. I’m most excited to bring the operational expertise I have in areas like manufacturing, supply chain and analytics. I believe that this will fit right in line with the direction that NuVasive is moving as we move into the next billion in revenue.”